Member Info for unvrkw

Chances are good, lets see what design freeze most likely this weeks bring and whether they confirm specific next steps around it. Whilst we know July, august to standardise, sept 100k, then 200k of a weekly volume we need to know adding £s to it and how it's sold. If similar to numbers banded on sky then we will see a positive so rise. Then everyone entitled will buy discounted shares to make a buck but then also giving odx the £3 million which in fact pays for the million tests a week. Slight delay in sp, orders, placing and anyone could suggested it's actually planned like this. Gla

I too watch the truck drivers from Kenya to Uganda on ch4 news. It’s not the fact their classes as super spreaders more they spend two weeks in a queue trying to cross from Kenya to Uganda having test after test. This is the type of location mologic work in and if there was ever a need for a 15 min POC antigen or/and antibody its here.

The economic harm, delays, problems is huge. A 45 mile queue to get from Kenya to Uganda that takes two weeks!!!

We don’t know half of what the world is experiencing, sat here referencing ourselves and thinking well I’m ok, I don’t need one so much be ok. Biggest test autumn and winter, huge potential impact so maybe tests rolling off the production line in sept onwards is timed just right.

Some good points overall, some understandable frustration and no doubt different thoughts pro and con. If you said to people Covid will need to be clearly managed next five years and winter periods might lead to significant problems then people view changes,

If you follow the stance virus problems may continue, diagnostic businesses are key? I note in the presentation they mentioned BBI and Odx making the RTC POC test so only the two? Their not doing all of this just for fun, they know something which is worth taking significant financial risk on. I’ve sold about 25% of my holding over last few months after holding several years. Done well so now back into invested for longer term, Odx had a huge boost so let’s now see what happens gla

A lot of the sales are “late summer”, September, October, November.

With mologic they are working on one test followed by the next which takes validation into sept, nov.

With the POC test for the RTC, even if design freeze this week orders and sales aren’t expected until sept.

Looking at everything they have declared capacity, highlighted margin and areas of focus, pretty clear. People become impatient and want results yesterday so I’m happy to ride this out, see what the next two months brings.

Covid will be a short term, risk proposition? Depending on what happens, could be huge if no vaccine, huge if countries struggle to manage.

I think Odx have set their stall out now pretty clearly, it’s all now about timelines, next sets and potential being turned into reality!! Gla

Mologic planned to expand their manufacturing also.

It’s not clear from mologic who is doing what but clear from Odx what they are doing for mologic

https://mologic.co.uk/news/

Also seems to depend on where in the world, how under developed, contacts as to who gets what.

Some quoted to be made for $1, then other tests like Elisa sold elsewhere.

It’s clear now we know what they can make, maybe they are going to support mologic with the very cheap tests also? Elisa no idea at selling price in different places?

The sp is stuck without orders even though it’s now clear what they are and will be capable of. Ceo isn’t stupid, he’s not committed to these changes without a pretty strong forecast and reasonably know future. They have many people on the ground, many labs, many Covid scientists understanding what is happening. Scene is set, it’s now playing out and design freeze I would think this week.

They might just sell straight onto amazon??

its one of the examples of the unanswered questions.

so if design freeze comes, validated and PHE approval which leads to a government order then everything is back on again. if the design freeze leads to some of the capacity now announced being realised we go up.

in the last week odx have confirmed finance, confirmed what they money will be spent on, therefore confirm capacity, margins and all that is left is ORDERS, pure and simple ORDERS. i think food intolerance and cd4 are progressing its just what is the extra bit on top for covid?????

I’ve not seen any updates from mologic in regards their new factory to make POC tests? It was announced but maybe they have worked around this now and more effective to do it through Odx?

They are matching capabilities with their science and lab work?

We dint know the sales potential hence slow down, shares traded today has really reduced back as people await design freeze, actual sales?

If Covid is over in three months then Odx is well and truly behind the curve, if it’s got two years or more to run and manage Odx have a hugely successful future. Bear in mind POC tests cost far less to buy than lab based do there maybe deals in place currently but if huge can be saved government will change its approach,

We are coming out of lockdown, time needed and weather impacts to really understand what is going to happen next.

The risks are far less than when at 60p just the impatience and appetite has changed, gla

totally agree merchant, the orders will either be there or not. the update clarifies what capacity is possible and the margins expected. whether rtc or mologic the production will be full if demand is there, they wont not use capacity if needed.

the only thing not guranteed by the bod understadbly is what exact orders will be like, they dont have them yet. they are progressing sales through all their standard channels, mologic channels and through RTC to the government, just need to wait to see what this looks like.

if they announce potential orders which never come off they will be accused of ramping. what we know is margins are good, capacity good both in covid and food intolerance, cd4. huge progress, happy to hold and at the moment i'll be buying my discounted shares. we will have design freeze before deadline of sharing placing

the covid urgency, feeling of disaster has subsided thats obvious and clear to see. industry, people and society intend to go back to normal, nothing is going to stop this now, not even the risk of a so called second wave.

so covid stocks arent in favour, feeling being that its over, tests sold will reduce and as written a feeling now that odx has missed the boat, all done and dusted.

whilst actually the number of cases is higher than ever especially in the americas and as society we have lived through the most severe lockdown ever which we are only just coming out of. there is a sense and believe by some that covid doesnt transmit as well in the heat and summer so will there be a second wave autumn to winter, so severe that it grinds things to a halt or not? this will have a big impact on covid test numbers which no one has any idea about now. if the numbers are big odx has played a blinder as just as things get bad the number of tests and great margin they can manufacturer will be higher than ever in all formats and test type. so the risk factor now is how long and impact of covid, will the increase in positive results in the usa turn into hospital admissions and deaths?

the antibody poc is wanted by many to find out whether they have had it, great sense and feeling its being here far longer than previously acknowledged so evidence is needed. the rtc test i believe will be PHE approved. the current M/Cap can be justified from cd4 and food intolerance sales, then there is covid, huge test capability and margins, just whether you believe they will sell.

all that is needed now is sale and order updates

I’m not so sure I agree completely in the comments from Dibs. The 200k to RTC, rest to mologic is positive, we don’t know why this is the % split and it simply could be that margins are Better in one group, ceo is splitting risk

The overall capable volume is huge compared to previously so irrespective of the RTC split then the message is positive and the number far in excess of before. I don’t think design freeze is in the sp, I think the Covid rush has slowed, people move on, become impatient so hence the sp moves plus people want to see orders and aren’t willing now just to believe.

The capacity and margins announced this morning are outstanding compared to previous updates, if the orders to fill this capacity came to pass the company will significantly increase in size and the dilution will seem like nothing.

Margins are high, volume potential huge so it’s now about actual delivery. I think % RTC share against mologic is a company decision based on current situation and having now alternative customer roots is far batter than the one! 200k POC per week 4 weeks ago would have been a fabulous result, it makes up 20% capacity now which Is huge and the fact we are also now looking at antigen and antibody POC is great achievement

It’s a million tests a week, 200k reserves for RTC and the test being used for mologic capacity.

Even off a $4.20 cd4 they make 70% margin

Covering off western and less developed countries is a very wise move

What’s the verdict?

We need actual orders and revenue to all the good stuff written above. Answers to potential is needed turning from that to actual?? So orders equals £s, equals value, equals sp increase.

I think there’s loads of investors hanging in here based on this potential so let’s see it turned into reality

70 p is conservative if numbers accompany actual updates on tests. Germany has had to put the country R rate to 1.79 due to the meat slaughtering business having over 600 with the virus from 1000. It’s stated it drops during warm weather, in the USA ironically the heat drives people inside and it spreads. The autumn, winter is the biggest challenging time to come and I think it takes a few months to come back at high, background numbers.

In the years I have owned Odx shares they have never over stated, over ramped, created hype around the share. The ceo has systematically turned the business around and update as and when. Never sent loads of rns out, simply communicated the basic which some probably don’t like.

They have always worked hard, tried their best, looked for £s and ethics and they have acted no different now to some people’s frustration,

If they deliver design freeze, numbers by end of next week and sp is 70 p plus everything else will be forgotten gla

With the design freeze they need numbers.

They need to share how long to actually make it, orders in uk, price to retail at, potential, global coverage and orders. If they give substance with the update and not simply say next stage, great potential then sp will move very well.

I’m keen to know what sales from all the mologic tests are coming, three POC tests distributed different countries? We need prices, costs, numbers and that’s what pushed sp up. Risk then is how long you choose to stay in.

Gla

This will work out however how big depends on later this year and were the virus takes us.

It’s becoming obvious and more evidence to show this was around far longer prior to everyone realising than first thought. The virus cases build, some overlap into hospitals which takes the time. We will see in the next month how this turns in the USA, up, down in hospital numbers.

Second waves, bad winter etc will push the value of everything odx can do up significantly so we shall see.

Placing good, holding until the 3rd, decision then made based on info shared, simple, gla

Also consider aspart if the business risk the other parts of the business. Cd4 is ground breaking and starting to find its way through, they have identified two further POC tests in this area to develop with great potential and food allergies full stop across the world.

Depending on how long you stay around POC diagnostic is obviously now in the lime light more than ever and has a growing future gla

Everyone will now wait and watch where the sp goes according to announcements. Everyone is critical of institutions investing however we will all take up the offering if 20% discount to the current sp. we will all be happy to take the discounted shares and then sell straight away or hold onto them.

All comes down to update on POC test, sales, sales, sales and profit generated. We haven’t got wind of anything in regards profit as yet so other aspects are de risking but they still need to sell. What is this potential?

POC test rumour millions in revenue, £10 each, 50% profit sold globally??

Neither have we any insight if antigen is worth anything, again I would think an antigen, accurate POC would sell extremely well.

Next week the sp will move closer or further away for 40p based on news , with this a backstopping number. No news next week will not be helpful when pretty much every RTC has said it will come.

If we have positive updates I could suggest the timing of the placing and price has been excellent. Everyone who owns shares can buy more at a discount to the current sp! It’s not that many shares still overall as a business, dilution happens and as some have highlighted it would have been suspicious if they hadn’t raised during this time, why? It’s going to be an interesting two weeks

So they have announced a placing which has been oversubscribed at 40p. Then offered to PIs at the same price with an action date up to the 3rd July right through the period where pretty much all RTC members have said the design freeze will be announced.

So they must know everyone will now hold and wait, no news it will dip below 40p, no one will pick up the options, good news, sp rises, full subscription of shares as everyone gets the discount.

Either the timings are spot on for the future and subscription or it's going to be a right **** show when no one takes up any of the offe, sits it out and sp dives.

That 3 million ish will be pretty handy, I like the fact it's not all for covid but also shows obviously there is mileage in Elisa and of course poc, lateral tests.

I also like the fact they are looking at margin improvement on cd4 and other areas of the business so it's an overall development as well as covid. The CEO no matter what the comments on here has made some pretty sound decisions so far for the business. I think he is pitching this right, they have developed covid poc, they have tied other deals as the demand is there and it's becoming a spring board to the next stage. How long covid will last no one know but the CEO is going to use this whatever to get odx to the next level.

Sure will be an interesting two weeks. Gla